ES2171465T3 - Inhibidor de la esterasa de c1 para reducir lesiones de miocardio durante un infarto de miocardio agudo. - Google Patents
Inhibidor de la esterasa de c1 para reducir lesiones de miocardio durante un infarto de miocardio agudo.Info
- Publication number
- ES2171465T3 ES2171465T3 ES94929047T ES94929047T ES2171465T3 ES 2171465 T3 ES2171465 T3 ES 2171465T3 ES 94929047 T ES94929047 T ES 94929047T ES 94929047 T ES94929047 T ES 94929047T ES 2171465 T3 ES2171465 T3 ES 2171465T3
- Authority
- ES
- Spain
- Prior art keywords
- esterase inhibitor
- miocard
- pct
- myocardial infarction
- acute myocardial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electrotherapy Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
UN METODO DE TRATAMIENTO TERAPEUTICO O PROFILACTICO DE LA INFARTACION MIOCARDICA AGUDA, QUE CONSISTE EN ADMINISTRAR UN INHIBIDOR DE LA ESTERASA C1 EXOGENO, POR SI SOLO O COMBINADO CON OTROS FARMACOS, A UN PACIENTE CON INFARTACION MIOCARDICA AGUDO O A UN PACIENTE CON RIESGO DE PADECER UN INFARTO DE MIOCARDIO AGUDO. EL TRATAMIENTO INHIBE LA REACCION INFLAMATORIA, Y DE MANERA MAS ESPECIFICA LA ACTIVACION DEL SISTEMA COMPLEMENTO, QUE TIENE LUGAR DURANTE UNA INFARTACION MIOCARDICA AGUDO. EL INHIBIDOR DE LA ESTERASA C1 PUEDE INCLUIR UN INHIBIDOR DE LA ESTERASA C1 PURIFICADO A PARTIR DE UN PLASMA O DE OTROS MATERIALES BIOLOGICOS, O UN INHIBIDOR DE LA ESTERASA C1 RECOMBINANTE, O ESTRUCTURAS RECOMBINANTES DE OTROS INHIBIDORES QUE POSEEN UNA ESPECIFICIDAD SIMILAR A LA DEL INHIBIDOR DE LA ESTERASA C1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93202572 | 1993-09-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2171465T3 true ES2171465T3 (es) | 2002-09-16 |
Family
ID=8214075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94929047T Expired - Lifetime ES2171465T3 (es) | 1993-09-01 | 1994-08-31 | Inhibidor de la esterasa de c1 para reducir lesiones de miocardio durante un infarto de miocardio agudo. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6090777A (es) |
EP (1) | EP0716611B1 (es) |
JP (2) | JP4077030B2 (es) |
AT (1) | ATE212859T1 (es) |
AU (1) | AU678064B2 (es) |
DE (1) | DE69429816T2 (es) |
DK (1) | DK0716611T3 (es) |
ES (1) | ES2171465T3 (es) |
PT (1) | PT716611E (es) |
WO (1) | WO1995006479A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19829014A1 (de) * | 1998-06-30 | 2000-01-05 | Centeon Pharma Gmbh | Modifizierter C1-Esterase-Inhibitor zur Blockierung der Infektiosität von HIV |
US7008645B2 (en) * | 1998-07-14 | 2006-03-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method of inhibiting restenosis using bisphosphonates |
CA2426115A1 (en) * | 2003-04-18 | 2004-10-18 | Victor Gurewich | Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
US20060051407A1 (en) * | 2003-06-27 | 2006-03-09 | Yoram Richter | Method of treating ischemia-reperfusion injury |
US10517883B2 (en) * | 2003-06-27 | 2019-12-31 | Zuli Holdings Ltd. | Method of treating acute myocardial infarction |
US20070196367A1 (en) * | 2006-02-22 | 2007-08-23 | Valentin Dinu | Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system |
US20090010916A1 (en) * | 2006-06-22 | 2009-01-08 | Victor Gurewich | C-1 Inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
PT3028716T (pt) | 2006-10-10 | 2020-11-23 | Regenesance B V | Inibição do complemento para regeneração nervosa melhorada |
JP6538561B2 (ja) | 2012-10-25 | 2019-07-03 | バイオベラティブ・ユーエスエイ・インコーポレイテッド | 抗補体C1s抗体とそれらの用途 |
CA2889197A1 (en) | 2012-11-02 | 2014-05-08 | True North Therapeutics, Inc. | Anti-complement c1s antibodies and uses thereof |
JP6289511B2 (ja) * | 2013-02-28 | 2018-03-07 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | 羊水塞栓の治療剤 |
AU2014224599B2 (en) | 2013-03-08 | 2018-11-08 | Csl Behring Gmbh | Treatment and prevention of remote ischemia-reperfusion injury |
US9993427B2 (en) | 2013-03-14 | 2018-06-12 | Biorest Ltd. | Liposome formulation and manufacture |
PT2968434T (pt) | 2013-03-15 | 2017-09-18 | Shire Viropharma Inc | Composições de c1-inh e para uso na prevenção e no tratamento de distúrbios associados a deficiência de inibidor da c1-esterase |
WO2014207199A1 (en) * | 2013-06-28 | 2014-12-31 | Csl Behring Gmbh | Combination therapy using a factor xii inhibitor and a c1-inhibitor |
EP3280440B1 (en) | 2015-04-06 | 2022-11-16 | Bioverativ USA Inc. | Humanized anti-c1s antibodies and methods of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3228502A1 (de) * | 1982-07-30 | 1984-02-02 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung des c1-inaktivators und seine verwendung |
FR2601034B1 (fr) * | 1986-07-03 | 1989-11-17 | Pasteur Institut | Inhibiteur de l'activite de la c1-esterase plasmatique (c1-inhibiteur) et d'autres enzymes proteolytiques du groupe des proteases a serine, son procede de preparation, acides nucleiques codant pour cet inhibiteur, methodes de detection d'affections correlees aux defauts dudit inhibiteur a l'aide d'anticorps ou de sondes nucleotidiques et medicaments contenant ledit inhibiteur de synthese |
WO1991006650A1 (en) * | 1989-10-27 | 1991-05-16 | Cetus Corporation | C1 inhibitor muteins and uses thereof |
WO1992022320A1 (en) * | 1991-06-14 | 1992-12-23 | Genentech, Inc. | C1 inhibitor variants and treating inflammatory response with c1 inhibitor |
-
1994
- 1994-08-31 US US08/604,933 patent/US6090777A/en not_active Expired - Lifetime
- 1994-08-31 AT AT94929047T patent/ATE212859T1/de active
- 1994-08-31 WO PCT/NL1994/000208 patent/WO1995006479A1/en active IP Right Grant
- 1994-08-31 AU AU78239/94A patent/AU678064B2/en not_active Expired
- 1994-08-31 DE DE69429816T patent/DE69429816T2/de not_active Expired - Lifetime
- 1994-08-31 EP EP94929047A patent/EP0716611B1/en not_active Expired - Lifetime
- 1994-08-31 DK DK94929047T patent/DK0716611T3/da active
- 1994-08-31 JP JP50804995A patent/JP4077030B2/ja not_active Expired - Lifetime
- 1994-08-31 ES ES94929047T patent/ES2171465T3/es not_active Expired - Lifetime
- 1994-08-31 PT PT94929047T patent/PT716611E/pt unknown
-
2007
- 2007-11-21 JP JP2007301371A patent/JP2008056705A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU7823994A (en) | 1995-03-22 |
ATE212859T1 (de) | 2002-02-15 |
DK0716611T3 (da) | 2002-05-21 |
PT716611E (pt) | 2002-06-28 |
JP2008056705A (ja) | 2008-03-13 |
JP4077030B2 (ja) | 2008-04-16 |
DE69429816D1 (de) | 2002-03-21 |
US6090777A (en) | 2000-07-18 |
EP0716611A1 (en) | 1996-06-19 |
EP0716611B1 (en) | 2002-02-06 |
JPH09501946A (ja) | 1997-02-25 |
WO1995006479A1 (en) | 1995-03-09 |
DE69429816T2 (de) | 2002-09-19 |
AU678064B2 (en) | 1997-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2171465T3 (es) | Inhibidor de la esterasa de c1 para reducir lesiones de miocardio durante un infarto de miocardio agudo. | |
MX9700237A (es) | Combinaciones inhibidoras de proteasa retroviral. | |
NO307027B1 (no) | Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader | |
MY129293A (en) | The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders | |
FI880464A0 (fi) | Bekaempningsmedel mot tandplaque och -karies. | |
EP1007556A4 (en) | TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
BR9908280A (pt) | Inibidores de enzimas de fosfolipase | |
HU9204029D0 (en) | Proteolytic enzym inhibitors | |
DE69410254D1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
IL110943A (en) | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders | |
DE69333639D1 (en) | Trypsininhibitoren | |
HU9501146D0 (en) | 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity | |
ATE252389T1 (de) | Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismus | |
DK0876158T3 (da) | Ny medicinsk anvendelse af en ACE-inhibitor til behandling af mavesurhedssymptomer | |
CZ157795A3 (en) | Pharmaceutical preparations for treating prostatitis | |
CA2170739A1 (en) | Method to reduce myocardial injury during acute myocardial infarction | |
BG103859A (en) | The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions | |
AU4390597A (en) | Combination therapy for treatment of arthritic diseases | |
AU5857899A (en) | Use of tgf-beta inhibitors for treating cerebral disorders | |
GEP19991605B (en) | Inhibitor, Its Obtaining and Use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 716611 Country of ref document: ES |